About this Journal Submit a Manuscript Table of Contents
ISRN Hepatology
Volume 2013 (2013), Article ID 541836, 20 pages
http://dx.doi.org/10.1155/2013/541836
Review Article

Gastrointestinal Bleeding in Cirrhotic Patients with Portal Hypertension

Department of Gastroenterology and Hepatology, HELIOS Klinikum Siegburg, Ringstraße 49, 53129 Siegburg, Germany

Received 30 May 2013; Accepted 29 June 2013

Academic Editors: A. Castiella, S.-S. Yang, and M.-H. Zheng

Copyright © 2013 Erwin Biecker. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. J. Groszmann, G. Garcia-Tsao, J. Bosch et al., “Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis,” The New England Journal of Medicine, vol. 353, no. 21, pp. 2254–2261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Christensen, L. Fauerholdt, P. Schlichting, E. Juhl, H. Poulsen, and N. Tygstrup, “Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone,” Gastroenterology, vol. 81, no. 5, pp. 944–952, 1981. View at Scopus
  3. R. De Franchis and M. Primignani, “Natural history of portal hypertension in patients with cirrhosis,” Clinics in Liver Disease, vol. 5, no. 3, pp. 645–663, 2001. View at Scopus
  4. G. D'Amico and A. Luca, “Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding,” Bailliere's Clinical Gastroenterology, vol. 11, no. 2, pp. 243–256, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Merli, G. Nicolini, S. Angeloni et al., “Incidence and natural history of small esophageal varices in cirrhotic patients,” Journal of Hepatology, vol. 38, no. 3, pp. 266–272, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. J. G. Abraldes, C. Villanueva, R. Bañares et al., “Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy,” Journal of Hepatology, vol. 48, no. 2, pp. 229–236, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Augustin, J. Altamirano, A. González et al., “Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding,” American Journal of Gastroenterology, vol. 106, no. 10, pp. 1787–1795, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Villanueva, M. Piqueras, C. Aracil et al., “A randomized controlled trial comparing ligation and sclerotherapy as emergency endoscopic treatment added to somatostatin in acute variceal bleeding,” Journal of Hepatology, vol. 45, no. 4, pp. 560–567, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Brocchi, G. Caletti, G. Brambilla et al., “Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study,” The New England Journal of Medicine, vol. 319, no. 15, pp. 983–989, 1988. View at Scopus
  10. G. Kleber, T. Sauerbruch, H. Ansari, and G. Paumgartner, “Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study,” Gastroenterology, vol. 100, no. 5 I, pp. 1332–1337, 1991. View at Scopus
  11. C. Merkel, M. Bolognesi, S. Bellon et al., “Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices,” Gastroenterology, vol. 102, no. 3, pp. 973–979, 1992. View at Scopus
  12. T. Sauerbruch, R. Wotzka, W. Kopcke et al., “Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients wih cirrhosis,” The New England Journal of Medicine, vol. 319, no. 1, pp. 8–15, 1988. View at Scopus
  13. R. D. Franchis, “Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension,” Journal of Hepatology, vol. 33, no. 5, pp. 846–852, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. G. D'Amico, L. Pagliaro, J. Bosch, and D. Patch, “Pharmacological treatment of portal hypertension: an evidence-based approach,” Seminars in Liver Disease, vol. 19, no. 4, pp. 475–505, 1999. View at Scopus
  15. G. Garcia-Tsao, “Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis,” Gastroenterology, vol. 120, no. 3, pp. 726–748, 2001. View at Scopus
  16. C. Merkel, R. Marin, P. Angeli et al., “A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis,” Gastroenterology, vol. 127, no. 2, pp. 476–484, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Zoli, C. Merkel, D. Magalotti et al., “Natural history of cirrhotic patients with small esophageal varices: a prospective study,” American Journal of Gastroenterology, vol. 95, no. 2, pp. 503–508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Biecker, L. Classen, T. Sauerbruch, and M. Schepke, “Does therapy of oesophageal varices influences the progression of varices?” European Journal of Gastroenterology and Hepatology, vol. 21, no. 7, pp. 751–755, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Turnes, J. C. Garcia-Pagan, J. G. Abraldes, M. Hernandez-Guerra, A. Dell'Era, and J. Bosch, “Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis,” American Journal of Gastroenterology, vol. 101, no. 3, pp. 506–512, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. U. Thalhieimer, C. K. Triantes, D. N. Samonakis, D. Patch, and A. K. Burroughs, “Infection, coagulation, and variceal bleeding in cirrhosis,” Gut, vol. 54, no. 4, pp. 556–563, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Feu, J. M. Bordas, A. Luca et al., “Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis,” Hepatology, vol. 18, no. 5, pp. 1082–1089, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Hobolth, S. Møller, H. Grønbæk, K. Roelsgaard, F. Bendtsen, and E. Feldager Hansen, “Carvedilol or propranolol in portal hypertension? A randomized comparison,” Scandinavian Journal of Gastroenterology, vol. 47, no. 4, pp. 467–474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. G. H. Lo, W. C. Chen, H. M. Wang, and H. C. Yu, “Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding,” Journal of Gastroenterology and Hepatology, vol. 27, pp. 1681–1687, 2012.
  24. D. Tripathi, J. W. Ferguson, N. Kochar et al., “Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed,” Hepatology, vol. 50, no. 3, pp. 825–833, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. J. C. García-Pagán, R. Morillas, R. Bañares et al., “Propranolol plus placebo versus propranolol plus isosorbide-5-mononitrate in the prevention of a first variceal bleed: a double-blind RCT,” Hepatology, vol. 37, no. 6, pp. 1260–1266, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. D. R. Abraczinskas, R. Ookubo, N. D. Grace et al., “Propranolol for the prevention of first esophageal variceal hemorrhage: a lifetime commitment?” Hepatology, vol. 34, no. 6, pp. 1096–1102, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. J. G. Abraldes, I. Tarantino, J. Turnes, J. C. Garcia-Pagan, J. Rodés, and J. Bosch, “Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis,” Hepatology, vol. 37, no. 4, pp. 902–908, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. G.-H. Lo, W.-C. Chen, M.-H. Chen et al., “Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis,” Gastrointestinal Endoscopy, vol. 59, no. 3, pp. 333–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. H. F. Lui, A. J. Stanley, E. H. Forrest et al., “Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate,” Gastroenterology, vol. 123, no. 3, pp. 735–744, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. S. K. Sarin, G. S. Lamba, M. Kumar, A. Misra, and N. S. Murthy, “Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding,” The New England Journal of Medicine, vol. 340, no. 13, pp. 988–993, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Schepke, G. Kleber, D. Nürnberg et al., “Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis,” Hepatology, vol. 40, no. 1, pp. 65–72, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. T. F. Imperiale and N. Chalasani, “A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding,” Hepatology, vol. 33, no. 4, pp. 802–807, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. L. L. Gluud and A. Krag, “Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults,” Cochrane Database of Systematic Reviews, vol. 8, Article ID CD004544, 2012.
  34. G. D'Amico and R. De Franchis, “Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators,” Hepatology, vol. 38, no. 3, pp. 599–612, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. P. A. McCormick and C. O'Keefe, “Improving prognosis following a first variceal haemorrhage over four decades,” Gut, vol. 49, no. 5, pp. 682–685, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Augustin, L. Muntaner, J. T. Altamirano et al., “Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis,” Clinical Gastroenterology and Hepatology, vol. 7, no. 12, pp. 1347–1354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. D. Y. Graham and J. L. Smith, “The course of patients after variceal hemorrhage,” Gastroenterology, vol. 80, no. 4, pp. 800–809, 1981. View at Scopus
  38. J. Goulis, A. Armonis, D. Patch, C. Sabin, L. Greenslade, and A. K. Burroughs, “Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage,” Hepatology, vol. 27, no. 5, pp. 1207–1212, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Bernard, J.-F. Cadranel, D. Valla, S. Escolano, V. Jarlier, and P. Opolon, “Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study,” Gastroenterology, vol. 108, no. 6, pp. 1828–1834, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Moitinho, À. Escorsell, J.-C. Bandi et al., “Prognostic value of early measurements of portal pressure in acute variceal bleeding,” Gastroenterology, vol. 117, no. 3, pp. 626–631, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Monescillo, F. Martínez-Lagares, L. Ruiz-Del-Arbol et al., “Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding,” Hepatology, vol. 40, no. 4, pp. 793–801, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Chalasani, C. Kahi, F. Francois et al., “Improved patient survival after acute variceal bleeding: a multicenter, cohort study,” American Journal of Gastroenterology, vol. 98, no. 3, pp. 653–659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Carbonell, A. Pauwels, L. Serfaty, O. Fourdan, V. G. Lévy, and R. Poupon, “Improved survival after variceal bleeding in patients with cirrhosis over the past two decades,” Hepatology, vol. 40, no. 3, pp. 652–659, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Cárdenas, P. Ginès, J. Uriz et al., “Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis,” Hepatology, vol. 34, no. 4 I, pp. 671–676, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. J. C. García-Pagán, E. Reverter, J. Abraldes, and J. Bosch, “Acute variceal bleeding,” Seminars in Respiratory and Critical Care Medicine, vol. 33, no. 1, pp. 46–54, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Bernard, J.-D. Grangé, E. N. Khac, X. Amiot, P. Opolon, and T. Poynard, “Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis,” Hepatology, vol. 29, no. 6, pp. 1655–1661, 1999. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Blaise, D. Pateron, J.-C. Trinchet, S. Levacher, M. Beaugrand, and J.-L. Pourriat, “Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage,” Hepatology, vol. 20, no. 1, pp. 34–38, 1994. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Fernández, L. R. del Arbol, C. Gómez et al., “Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage,” Gastroenterology, vol. 131, no. 4, pp. 1049–1056, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. M.-C. Hou, H.-C. Lin, T.-T. Liu et al., “Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial,” Hepatology, vol. 39, no. 3, pp. 746–753, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Soares-Weiser, M. Brezis, R. Tur-Kaspa, M. Paul, J. Yahav, and L. Leibovici, “Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials,” Scandinavian Journal of Gastroenterology, vol. 38, no. 2, pp. 193–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Rimola, G. García-Tsao, M. Navasa et al., “Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document,” Journal of Hepatology, vol. 32, no. 1, pp. 142–153, 2000. View at Scopus
  52. B. Castañeda, J. Morales, R. Lionetti et al., “Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats,” Hepatology, vol. 33, no. 4, pp. 821–825, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Villanueva, A. Colomo, A. Bosch et al., “Transfusion strategies for acute upper gastrointestinal bleeding,” The New England Journal of Medicine, vol. 368, pp. 11–21, 2013.
  54. S. Augustin, A. Gonzalez, and J. Genesca, “Acute esophageal variceal bleeding: current strategies and new perspectives,” World Journal of Hepatology, vol. 2, pp. 261–274, 2010.
  55. A. Tripodi and P. M. Mannucci, “Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research,” Journal of Hepatology, vol. 46, no. 4, pp. 727–733, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. R. Bañares, A. Albillos, D. Rincón et al., “Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis,” Hepatology, vol. 35, no. 3, pp. 609–615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. C. Villanueva, J. Ortiz, J. Miana et al., “Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding,” Gastroenterology, vol. 121, no. 1, pp. 110–117, 2001. View at Scopus
  58. J. C. García-Pagán, A. Escorsell, E. Moitinho, and J. Bosch, “Influence of pharmacological agents on portal hemodynamics: basis for its use in the treatment of portal hypertension,” Seminars in Liver Disease, vol. 19, no. 4, pp. 427–438, 1999. View at Scopus
  59. G. D'Amico, G. Pietrosi, I. Tarantino, and L. Pagliaro, “Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a cochrane meta-analysis,” Gastroenterology, vol. 124, no. 5, pp. 1277–1291, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Nidegger, S. Ragot, P. Berthelémy et al., “Cirrhosis and bleeding: the need for very early management,” Journal of Hepatology, vol. 39, pp. 509–514, 2003.
  61. S. Levacher, P. Letoumelin, D. Pateron, M. Blaise, C. Lapandry, and J.-L. Pourriat, “Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients,” Lancet, vol. 346, no. 8979, pp. 865–868, 1995. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Avgerinos, F. Nevens, S. Raptis, and J. Fevery, “Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial,” Lancet, vol. 350, no. 9090, pp. 1495–1499, 1997. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Calès, C. Masliah, B. Bernard et al., “Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension,” The New England Journal of Medicine, vol. 344, pp. 23–28, 2001.
  64. H. O. Conn, G. R. Ramsey, and E. H. Storer, “Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial,” Gastroenterology, vol. 68, no. 2, pp. 211–221, 1975. View at Scopus
  65. J. Bosch, R. J. Groszmann, J. C. Garcia-Pagan et al., “Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial,” Hepatology, vol. 10, no. 6, pp. 962–968, 1989. View at Scopus
  66. A. E. S. Gimson, D. Westaby, and J. Hegarty, “A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage,” Hepatology, vol. 6, no. 3, pp. 410–413, 1986. View at Scopus
  67. M. R. Fogel, C. M. Knauer, and L. L. Andres, “Continuous intravenous vasopressin in active upper gastrointestinal bleeding. A placebo-controlled trial,” Annals of Internal Medicine, vol. 96, no. 5, pp. 565–569, 1982. View at Scopus
  68. A. Mallory, J. W. Schaefer, and J. R. Cohen, “Selective intra-arterial vasopressin infusion for upper gastrointestinal tract hemorrhage. A controlled trial,” Archives of Surgery, vol. 115, no. 1, pp. 30–32, 1980. View at Scopus
  69. T. C. Merigan Jr., G. R. Plotkin, and C. S. Davidson, “Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. A controlled evaluation,” The New England Journal of Medicine, vol. 266, pp. 134–135, 1962.
  70. F. Nevens, “Non-invasive variceal pressure measurements: validation and clinical implications,” Verhandelingen-Koninklijke Academie voor Geneeskunde van België, vol. 58, no. 4, pp. 413–437, 1996. View at Scopus
  71. R. Moreau, O. Soubrane, A. Hadengue et al., “Hemodynamic responses to the administration of terlipressin alone and combined with nitroglycerin in patients with cirrhosis,” Gastroentérologie Clinique et Biologique, vol. 16, no. 8-9, pp. 680–686, 1992 (French). View at Scopus
  72. À. Escorsell, J. C. Bandi, E. Moitinho et al., “Time profile of the haemodynamic effects of terlipressin in portal hypertension,” Journal of Hepatology, vol. 26, no. 3, pp. 621–627, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. J. G. Freeman, I. Cobden, and O. Record Ch., “Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding,” Journal of Clinical Gastroenterology, vol. 11, no. 1, pp. 58–60, 1989. View at Scopus
  74. C. Soderlund, I. Magnusson, S. Torngren, and L. Lundell, “Terlipressin (Triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial,” Scandinavian Journal of Gastroenterology, vol. 25, no. 6, pp. 622–630, 1990. View at Scopus
  75. G. N. Ioannou, J. Doust, and D. C. Rockey, “Systematic review: terlipressin in acute oesophageal variceal haemorrhage,” Alimentary Pharmacology and Therapeutics, vol. 17, no. 1, pp. 53–64, 2003. View at Publisher · View at Google Scholar · View at Scopus
  76. À. Escorsell, L. Ruiz Del Arbol, R. Planas et al., “Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST Study,” Hepatology, vol. 32, no. 3, pp. 471–476, 2000. View at Scopus
  77. E. Solà, S. Lens, M. Guevara et al., “Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension,” Hepatology, vol. 52, no. 5, pp. 1783–1790, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. K.-W. Chiu, I.-S. Sheen, and Y.-F. Liaw, “A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices,” Journal of Gastroenterology and Hepatology, vol. 5, no. 5, pp. 549–553, 1990. View at Scopus
  79. G. D'Amico, M. Traina, G. Vizzini et al., “Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial,” Journal of Hepatology, vol. 20, no. 2, pp. 206–212, 1994. View at Scopus
  80. C. Silvain, S. Carpentier, D. Sautereau et al., “Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial,” Hepatology, vol. 18, no. 1, pp. 61–65, 1993. View at Publisher · View at Google Scholar · View at Scopus
  81. S. Walker, H.-P. Kreichgauer, and J. C. Bode, “Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices—final report of a placebo-controlled, double-blind study,” Zeitschrift für Gastroenterologie, vol. 34, no. 10, pp. 692–698, 1996. View at Scopus
  82. I. Cirera, F. Feu, A. Luca et al., “Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation,” Hepatology, vol. 22, no. 1, pp. 106–111, 1995. View at Publisher · View at Google Scholar · View at Scopus
  83. F. Nevens, D. Sprengers, and J. Fevery, “The effect of different doses of a bolus injection of somatostatin combined with a slow infusion on transmural oesophageal variceal pressure in patients with cirrhosis,” Journal of Hepatology, vol. 20, no. 1, pp. 27–31, 1994. View at Scopus
  84. A. K. Burroughs, P. A. McCormick, M. D. Hughes, D. Sprengers, F. D'Heygere, and N. McIntyre, “Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding: emergency control and prevention of early variceal rebleeding,” Gastroenterology, vol. 99, no. 5, pp. 1388–1395, 1990. View at Scopus
  85. P. C. Gøtzsche, I. Gjørup, H. Bonnén, N. E. B. Brahe, U. Becker, and F. Burcharth, “Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis,” British Medical Journal, vol. 310, no. 6993, pp. 1495–1498, 1995. View at Scopus
  86. E. Moitinho, R. Planas, R. Baares et al., “Multicenter randomized controlled trial comparing different schedules of somatostatin in the treatment of acute variceal bleeding,” Journal of Hepatology, vol. 35, no. 6, pp. 712–718, 2001. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Bagarani, V. Albertini, and M. Anza, “Effect of somatostatin in controlling bleeding from esophageal varices,” Italian Journal of Surgical Sciences, vol. 17, no. 1, pp. 21–26, 1987. View at Scopus
  88. S. A. Jenkins, D. M. Nott, and J. N. Baxter, “Pharmacokinetics of octreotide in patients with cirrhosis and portal hypertension; Relationship between the plasma levels of the analogue and the magnitude and duration of the reduction in corrected wedged hepatic venous pressure,” HPB Surgery, vol. 11, no. 1, pp. 13–21, 1998. View at Scopus
  89. S. Møller, K. Brinch, J. H. Henriksen, and U. Becker, “Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis,” Journal of Hepatology, vol. 26, no. 5, pp. 1026–1033, 1997. View at Publisher · View at Google Scholar · View at Scopus
  90. À. Escorsell, J. C. Bandi, V. Andreu et al., “Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension,” Gastroenterology, vol. 120, no. 1, pp. 161–169, 2001. View at Scopus
  91. P. C. Gotzsche, “Somatostatin or octreotide for acute bleeding oesophageal varices,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD000193, 2000. View at Scopus
  92. H.-C. Lin, Y.-Y. Yang, M.-C. Hou et al., “Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis,” Scandinavian Journal of Gastroenterology, vol. 37, no. 4, pp. 482–487, 2002. View at Publisher · View at Google Scholar · View at Scopus
  93. D. A. Corley, J. P. Cello, W. Adkisson, W.-F. Ko, and K. Kerlikowske, “Octreotide for acute esophageal variceal bleeding: a meta-analysis,” Gastroenterology, vol. 120, no. 4, pp. 946–954, 2001. View at Scopus
  94. J. G. Abraldes and J. Bosch, “Somatostatin and analogues in portal hypertension,” Hepatology, vol. 35, no. 6, pp. 1305–1312, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. G. Ioannou, J. Doust, and D. C. Rockey, “Terlipressin for acute esophageal variceal hemorrhage,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD002147, 2001. View at Scopus
  96. G.-H. Lo, K.-H. Lai, W.-W. Ng et al., “Injection sclerotherapy preceded by esophageal tamponade versus immediate sclerotherapy in arresting active variceal bleeding: a prospective randomized trial,” Gastrointestinal Endoscopy, vol. 38, no. 4, pp. 421–424, 1992. View at Scopus
  97. D. Westaby, P. C. Hayes, A. E. S. Gimson, R. J. Polson, and R. Williams, “Controlled clinical trial of injection sclerotherapy for active variceal bleeding,” Hepatology, vol. 9, no. 2, pp. 274–277, 1989. View at Scopus
  98. M. Moreto, M. Zaballa, A. Bernal, S. Ibanez, E. Ojembarrena, and A. Rodriguez, “A randomized trial of tamponade or sclerotherpay as immediate treatment for bleeding esophageal varices,” Surgery Gynecology and Obstetrics, vol. 167, no. 4, pp. 331–334, 1988. View at Scopus
  99. K.-J. Paquet and H. Feussner, “Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: a prospective controlled randomized trial,” Hepatology, vol. 5, no. 4, pp. 580–583, 1985. View at Scopus
  100. G. Van Stiegmann and J. S. Goff, “Endoscopic esophageal varix ligation: preliminary clinical experience,” Gastrointestinal Endoscopy, vol. 34, no. 2, pp. 113–117, 1988. View at Scopus
  101. L. Laine, H. M. El-Newihi, B. Migikovsky, R. Sloane, and F. Garcia, “Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices,” Annals of Internal Medicine, vol. 119, no. 1, pp. 1–7, 1993. View at Scopus
  102. G.-H. Lo, K.-H. Lai, J.-S. Cheng et al., “Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices,” Hepatology, vol. 25, no. 5, pp. 1101–1104, 1997. View at Scopus
  103. G. V. Stiegmann, J. S. Goff, P. A. Michaletz-Onody et al., “Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices,” The New England Journal of Medicine, vol. 326, no. 23, pp. 1527–1532, 1992. View at Scopus
  104. J. J. Y. Sung, S. C. S. Chung, M. Y. Yung et al., “Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation,” Lancet, vol. 346, no. 8991-8992, pp. 1666–1669, 1995. View at Scopus
  105. C. Villanueva, J. Ortiz, M. Sàbat et al., “Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial,” Hepatology, vol. 30, no. 2, pp. 384–389, 1999. View at Publisher · View at Google Scholar · View at Scopus
  106. G.-H. Lo, W.-C. Chen, H.-H. Chan et al., “A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding,” Journal of Gastroenterology and Hepatology, vol. 24, no. 6, pp. 982–987, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. R. W. Sengstaken and A. H. Blakemore, “Balloon tamponage for the control of hemorrhage from esophageal varices,” Annals of surgery, vol. 131, no. 5, pp. 781–789, 1950. View at Scopus
  108. J. Teres, A. Cecilia, J. M. Bordas, A. Rimola, C. Bru, and J. Rodes, “Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube,” Gastroenterology, vol. 75, no. 4, pp. 566–569, 1978. View at Scopus
  109. J. Panes, J. Teres, J. Bosch, and J. Rodes, “Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes,” Digestive Diseases and Sciences, vol. 33, no. 4, pp. 454–459, 1988. View at Scopus
  110. D. Cook and L. Laine, “Indications, technique, and complications of balloon tamponade for variceal gastrointestinal bleeding,” Journal of Intensive Care Medicine, vol. 7, no. 4, pp. 212–218, 1992. View at Scopus
  111. F. Maufa and F. H. Al-Kawas, “Role of self-expandable metal stents in acute variceal bleeding,” International Journal of Hepatology, vol. 2012, Article ID 418369, 6 pages, 2012. View at Publisher · View at Google Scholar
  112. A. Dechêne, A. H. El Fouly, L. P. Bechmann et al., “Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents,” Digestion, vol. 85, no. 3, pp. 185–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. R. Hubmann, G. Bodlaj, M. Czompo et al., “The use of self-expanding metal stents to treat acute esophageal variceal bleeding,” Endoscopy, vol. 38, no. 9, pp. 896–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  114. G. Wright, H. Lewis, B. Hogan, A. Burroughs, D. Patch, and J. O'Beirne, “A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center,” Gastrointestinal Endoscopy, vol. 71, no. 1, pp. 71–78, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Zehetner, A. Shamiyeh, W. Wayand, and R. Hubmann, “Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent,” Surgical Endoscopy and Other Interventional Techniques, vol. 22, no. 10, pp. 2149–2152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. R. Jalan, R. A. Elton, D. N. Redhead, N. D. C. Finlayson, and P. C. Hayes, “Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage,” Journal of Hepatology, vol. 23, no. 2, pp. 123–128, 1995. View at Publisher · View at Google Scholar · View at Scopus
  117. P. A. McCormick, R. Dick, J. Chin et al., “Transjugular intrahepatic portosystemic stent-shunt,” British Journal of Hospital Medicine, vol. 49, no. 11, pp. 791–796, 1993. View at Scopus
  118. A. J. Sanyal, A. M. Freedman, V. A. Luketic et al., “Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy,” Gastroenterology, vol. 111, no. 1, pp. 138–146, 1996. View at Publisher · View at Google Scholar · View at Scopus
  119. R. Jalan, E. H. Forrest, A. J. Stanley et al., “A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices,” Hepatology, vol. 26, no. 5, pp. 1115–1122, 1997. View at Scopus
  120. M. Rössle, P. Deibert, K. Haag et al., “Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding,” Lancet, vol. 349, no. 9058, pp. 1043–1049, 1997. View at Publisher · View at Google Scholar · View at Scopus
  121. A. J. Sanyal, A. M. Freedman, V. A. Luketic et al., “The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts,” Gastroenterology, vol. 112, no. 3, pp. 889–898, 1997. View at Publisher · View at Google Scholar · View at Scopus
  122. N. Jabbour, A. B. Zajko, P. D. Orons et al., “Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients,” Liver Transplantation and Surgery, vol. 2, no. 2, pp. 139–147, 1996. View at Scopus
  123. A. M. Freedman, A. J. Sanyal, J. Tisnado et al., “Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review,” Radiographics, vol. 13, no. 6, pp. 1185–1210, 1993. View at Scopus
  124. A. J. Sanyal, A. M. Freedman, and P. P. Purdum III, “TIPS-associated hemolysis and encephalopathy,” Annals of Internal Medicine, vol. 117, no. 5, pp. 443–444, 1992. View at Scopus
  125. C. Bureau, J. C. Garcia-Pagan, P. Otal et al., “Improved clinical outcome using polytetrafluoroethylene-coated stents for tips: results of a randomized study,” Gastroenterology, vol. 126, no. 2, pp. 469–475, 2004. View at Publisher · View at Google Scholar · View at Scopus
  126. J. C. Garcia-Pagan, K. Caca, C. Bureau et al., “Early use of TIPS in patients with cirrhosis and variceal bleeding,” The New England Journal of Medicine, vol. 362, pp. 2370–2379, 2010.
  127. D. Thabut, M. Rudler, and D. Lebrec, “Early TIPS with covered stents in high-risk patients with cirrhosis presenting with variceal bleeding: are we ready to dive into the deep end of the pool?” Journal of Hepatology, vol. 55, no. 5, pp. 1148–1149, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. A. S. Rosemurgy, S. E. Goode, B. R. Zwiebel, T. J. Black, and P. G. Brady, “A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices,” Annals of Surgery, vol. 224, no. 3, pp. 378–386, 1996. View at Publisher · View at Google Scholar · View at Scopus
  129. J. Teres, R. Baroni, J. M. Bordas, J. Visa, C. Pera, and J. Rodes, “Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding,” Journal of Hepatology, vol. 4, no. 2, pp. 159–167, 1987. View at Scopus
  130. K. Bari and G. Garcia-Tsao, “Treatment of portal hypertension,” World Journal of Gastroenterology, vol. 18, no. 11, pp. 1166–1175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. I. B. Buchwalow, T. Podzuweit, W. Böcker et al., “Vascular smooth muscle and nitric oxide synthase,” FASEB Journal, vol. 16, no. 6, pp. 500–508, 2002. View at Publisher · View at Google Scholar · View at Scopus
  132. A. K. Burroughs, W. J. Jenkins, and S. Sherlock, “Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis,” The New England Journal of Medicine, vol. 309, no. 25, pp. 1539–1542, 1983. View at Scopus
  133. M. Colombo, R. De Franchis, M. Tommasini, A. Sangiovanni, and N. Dioguardi, “β-Blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial,” Hepatology, vol. 9, no. 3, pp. 433–438, 1989. View at Scopus
  134. O. J. Garden, H. Motyl, and W. H. Gilmour, “Prediction of outcome following acute variceal haemorrhage,” British Journal of Surgery, vol. 72, no. 2, pp. 91–95, 1985. View at Scopus
  135. A. Gatta, C. Merkel, and D. Sacerdoti, “Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial,” Digestion, vol. 37, no. 1, pp. 22–28, 1987. View at Scopus
  136. A. M. Queuniet, P. Czernichow, E. Lerebours, P. Ducrotte, J. L. Tranvouez, and R. Colin, “Controlled study of propranolol in the prevention of recurrent hemorrhage in cirrhotic patients,” Gastroentérologie Clinique et Biologique, vol. 11, pp. 41–47, 1987 (French).
  137. V. Rossi, P. Cales, P. Burtin et al., “Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy,” Journal of Hepatology, vol. 12, no. 3, pp. 283–289, 1991. View at Scopus
  138. I. S. Sheen, T. Y. Chen, and Y. F. Liaw, “Randomized controlled study of propranolol for prevention of recurrent esophageal varices bleeding in patients with cirrhosis,” Liver, vol. 9, no. 1, pp. 1–5, 1989. View at Scopus
  139. J.-P. Villeneuve, G. Pomier-Layrargues, and C. Infante-Rivard, “Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial,” Hepatology, vol. 6, no. 6, pp. 1239–1243, 1986. View at Scopus
  140. J. C. Garcia-Pagan, F. Feu, J. Bosch, and J. Rodes, “Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: a randomized controlled study,” Annals of Internal Medicine, vol. 114, no. 10, pp. 869–873, 1991. View at Scopus
  141. F. Feu, J.-C. Garcia-Pagan, J. Bosch et al., “Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis,” Lancet, vol. 346, no. 8982, pp. 1056–1059, 1995. View at Scopus
  142. D. Patch, C. A. Sabin, J. Goulis et al., “A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis,” Gastroenterology, vol. 123, no. 4, pp. 1013–1019, 2002. View at Publisher · View at Google Scholar · View at Scopus
  143. C. Villanueva, J. Balanzó, M. T. Novella et al., “Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding,” The New England Journal of Medicine, vol. 334, no. 25, pp. 1624–1629, 1996. View at Publisher · View at Google Scholar · View at Scopus
  144. T. I. A. Sorensen, “Sclerotherapy after first variceal hemorrhage in cirrhosis: a randomized multicenter trial,” The New England Journal of Medicine, vol. 311, no. 25, pp. 1594–1600, 1984. View at Scopus
  145. J. Korula, L. A. Balart, and G. Radvan, “A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy,” Hepatology, vol. 5, no. 4, pp. 584–589, 1985. View at Scopus
  146. C. Soderlund and T. Ihre, “Endoscopic sclerotherapy v. conservative management of bleeding oesophageal varices. A 5-year prospective controlled trial of emergency and long-term treatment,” Acta Chirurgica Scandinavica, vol. 151, no. 5, pp. 449–456, 1985. View at Scopus
  147. J. Terblanche, P. C. Bornman, and D. Kahn, “Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial,” Lancet, vol. 2, no. 8363, pp. 1328–1332, 1983. View at Scopus
  148. D. Westaby, B. R. D. Macdougall, and R. Williams, “Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial,” Hepatology, vol. 5, no. 5, pp. 827–830, 1985. View at Scopus
  149. S. Dasarathy, M. Dwivedi, D. K. Bhargava, K. R. Sundaram, and K. Ramachandran, “A prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child class B and C) cirrhotic patients,” Hepatology, vol. 16, no. 1, pp. 89–94, 1992. View at Publisher · View at Google Scholar · View at Scopus
  150. D. Westaby, R. J. Polson, A. E. S. Gimson, P. C. Hayes, K. Hayllar, and R. Williams, “A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding,” Hepatology, vol. 11, no. 3, pp. 353–359, 1990. View at Scopus
  151. J. M. Dollet, B. Champigneulle, A. Patris, M. A. Bigard, and P. Gaucher, “Endoscopic sclerotherapy versus oral propranolol after variceal hemorrhage in cirrhosis: results of a 4-year prospective randomized trial,” Gastroentérologie Clinique et Biologique, vol. 12, no. 3, pp. 234–239, 1988 (French). View at Scopus
  152. T. Martin, A. Taupignon, A. Lavignolle, D. Perrin, and L. Le Bodic, “Prevention of recurrent bleeding in patients with cirrhosis. Results of a controlled trial of propranolol versus endoscopic sclerotherapy,” Gastroentérologie Clinique et Biologique, vol. 15, no. 11, pp. 833–837, 1991 (French). View at Scopus
  153. J. Teres, J. Bosch, J. M. Bordas et al., “Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial,” Gastroenterology, vol. 105, no. 5, pp. 1508–1514, 1993. View at Scopus
  154. A. E. S. Gimson, J. K. Ramage, M. Z. Panos et al., “Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices,” Lancet, vol. 342, no. 8868, pp. 391–394, 1993. View at Publisher · View at Google Scholar · View at Scopus
  155. M. Hashizume, M. Ohta, K. Ueno, K. Tanoue, S. Kitano, and K. Sugimachi, “Endoscopic ligation of esophageal varices compared with injection sclerotherapy: a prospective randomized trial,” Gastrointestinal Endoscopy, vol. 39, no. 2, pp. 123–126, 1993. View at Scopus
  156. M.-C. Hou, H.-C. Lin, B. I.-T. Kuo, C.-H. Chen, F.-Y. Lee, and S.-D. Lee, “Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial,” Hepatology, vol. 21, no. 6, pp. 1517–1522, 1995. View at Publisher · View at Google Scholar · View at Scopus
  157. L. Laine and D. Cook, “Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis,” Annals of Internal Medicine, vol. 123, no. 4, pp. 280–287, 1995. View at Scopus
  158. G.-H. Lo, K.-H. Lai, J.-S. Cheng et al., “A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices,” Hepatology, vol. 22, no. 2, pp. 466–471, 1995. View at Publisher · View at Google Scholar · View at Scopus
  159. C. Villanueva, J. Minana, J. Ortiz et al., “Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding,” The New England Journal of Medicine, vol. 345, no. 9, pp. 647–655, 2001. View at Publisher · View at Google Scholar · View at Scopus
  160. G.-H. Lo, W.-C. Chen, M.-H. Chen et al., “Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding,” Gastroenterology, vol. 123, no. 3, pp. 728–734, 2002. View at Publisher · View at Google Scholar · View at Scopus
  161. J. De La Peña, E. Brullet, E. Sanchez-Hernández et al., “Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial,” Hepatology, vol. 41, no. 3, pp. 572–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  162. J. C. García-Pagán, C. Villanueva, A. Albillos et al., “Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial,” Gut, vol. 58, no. 8, pp. 1144–1150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  163. A. Kumar, S. K. Jha, P. Sharma et al., “Addition of Propranolol and Isosorbide Mononitrate to Endoscopic Variceal Ligation Does Not Reduce Variceal Rebleeding Incidence,” Gastroenterology, vol. 137, no. 3, pp. 892–901, 2009. View at Publisher · View at Google Scholar · View at Scopus
  164. G.-H. Lo, K.-H. Lai, J.-S. Cheng et al., “Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial,” Hepatology, vol. 32, no. 3, pp. 461–465, 2000. View at Scopus
  165. J. Cabrera, M. Maynar, R. Granados et al., “Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage,” Gastroenterology, vol. 110, no. 3, pp. 832–839, 1996. View at Publisher · View at Google Scholar · View at Scopus
  166. J. P. Cello, E. J. Ring, E. W. Olcott et al., “Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized, controlled trial,” Annals of Internal Medicine, vol. 126, no. 11, pp. 858–865, 1997. View at Scopus
  167. L. García-Villarreal, F. Martínez-Lagares, A. Sierra et al., “Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage,” Hepatology, vol. 29, no. 1, pp. 27–32, 1999. View at Publisher · View at Google Scholar · View at Scopus
  168. M. Merli, F. Salerno, O. Riggio et al., “Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial,” Hepatology, vol. 27, no. 1, pp. 48–53, 1998. View at Publisher · View at Google Scholar · View at Scopus
  169. A. J. Sanyal, A. M. Freedman, V. A. Luketic et al., “Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized, controlled trial,” Annals of Internal Medicine, vol. 126, no. 11, pp. 849–857, 1997. View at Scopus
  170. P. Sauer, L. Theilmann, W. Stremmel, C. Benz, G. M. Richter, and A. Stiehl, “Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding,” Gastroenterology, vol. 113, no. 5, pp. 1623–1631, 1997. View at Publisher · View at Google Scholar · View at Scopus
  171. V. Gülberg, M. Schepke, G. Geigenberger et al., “Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial,” Scandinavian Journal of Gastroenterology, vol. 37, no. 3, pp. 338–343, 2002. View at Publisher · View at Google Scholar · View at Scopus
  172. A. Luca, G. D'Amico, R. La Galla, M. Midiri, A. Morabito, and L. Pagliaro, “TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials,” Radiology, vol. 212, no. 2, pp. 411–421, 1999. View at Scopus
  173. G. V. Papatheodoridis, J. Goulis, G. Leandro, D. Patch, and A. K. Burroughs, “Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis,” Hepatology, vol. 30, no. 3, pp. 612–622, 1999. View at Publisher · View at Google Scholar · View at Scopus
  174. M. Zheng, Y. Chen, J. Bai et al., “Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondary prophylaxis of variceal rebleeding in cirrhotic patients: meta-analysis update,” Journal of Clinical Gastroenterology, vol. 42, no. 5, pp. 507–516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  175. N. D. Grace, H. O. Conn, R. H. Resnick et al., “Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: a randomized controlled trial,” Hepatology, vol. 8, no. 6, pp. 1475–1481, 1988. View at Scopus
  176. H. A. J. Harley, T. Morgan, and A. G. Redeker, “Results of randomized trial of end-to-side portocaval shunt and distal splenorenal shunt in alcoholic liver disease and variceal bleeding,” Gastroenterology, vol. 91, no. 4, pp. 802–809, 1986. View at Scopus
  177. J. M. Henderson, M. H. Kutner, W. J. Millikan Jr. et al., “Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial,” Annals of Internal Medicine, vol. 112, no. 4, pp. 262–269, 1990. View at Scopus
  178. B. Langer, B. R. Taylor, and D. R. MacKenzie, “Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt. An analysis of encephalopathy, survival, and quality of life,” Gastroenterology, vol. 88, no. 2, pp. 424–429, 1985. View at Scopus
  179. W. J. Millikan Jr., W. D. Warren, and J. M. Henderson, “The Emory prospective randomized trial: selective versus nonselective shunt to control variceal bleeding. Ten-year follow-up,” Annals of Surgery, vol. 201, no. 6, pp. 712–722, 1985. View at Scopus
  180. R. Planas, J. Boix, M. Broggi et al., “Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage,” Gastroenterology, vol. 100, no. 4, pp. 1078–1086, 1991. View at Scopus
  181. F. A. Reichle, W. F. Fahmy, and M. Golsorkhi, “Prospective comparative clinical trial with distal splenorenal and mesocaval shunts,” American Journal of Surgery, vol. 137, no. 1, pp. 13–21, 1979. View at Scopus
  182. R. H. Resnick, F. L. Iber, and A. M. Ishihara, “A controlled study of the therapeutic portacaval shunt,” Gastroenterology, vol. 67, no. 5, pp. 843–857, 1974. View at Scopus
  183. T. B. Reynolds, A. J. Donovan, and W. P. Mikkelsen, “Results of a 12-year randomized trial of portacaval shunt in patients with alcoholic liver disease and bleeding varices,” Gastroenterology, vol. 80, no. 5, pp. 1005–1011, 1981. View at Scopus
  184. B. Rueff, D. Prandi, F. Degos et al., “A controlled study of therapeutic portacaval shunt in alcoholic cirrhosis,” Lancet, vol. 1, no. 7961, pp. 655–659, 1976. View at Scopus
  185. G. P. Spina, R. Santambrogio, E. Opocher et al., “Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal rebleeding. First stage of a randomized, controlled trial,” Annals of Surgery, vol. 211, no. 2, pp. 178–186, 1990. View at Scopus
  186. L. F. Rikkers, G. Jin, D. A. Burnett et al., “Shunt surgery versus endoscopic sclerotherapy for variceal hemorrhage: late results of a randomized trial,” American Journal of Surgery, vol. 165, no. 1, pp. 27–33, 1993. View at Scopus
  187. A. S. Rosemurgy, F. M. Serafini, B. R. Zweibel et al., “Transjugular intrahepatic portosystemic shunt vs. small-diameter prosthetic h-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial,” Journal of Gastrointestinal Surgery, vol. 4, no. 6, pp. 589–597, 2000. View at Scopus
  188. S. Khan, C. Tudur Smith, P. Williamson, and R. Sutton, “Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD000553, 2006. View at Scopus
  189. S. K. Sarin, D. Lahoti, S. P. Saxena, N. S. Murthy, and U. K. Makwana, “Prevalence, classification and natural history of gastric varices: a long- term follow-up study in 568 portal hypertension patients,” Hepatology, vol. 16, no. 6, pp. 1343–1349, 1992. View at Publisher · View at Google Scholar · View at Scopus
  190. J. Bosch, J. G. Abraldes, and R. Groszmann, “Current management of portal hypertension,” Journal of Hepatology, Supplement, vol. 38, no. 1, pp. S54–S68, 2003. View at Scopus
  191. T. Tajiri, M. Onda, H. Yoshida, Y. Mamada, N. Taniai, and K. Yamashita, “The natural history of gastric varices,” Hepato-Gastroenterology, vol. 49, no. 46, pp. 1180–1182, 2002. View at Scopus
  192. M. Schepke, E. Biecker, B. Appenrodt, J. Heller, and T. Sauerbruch, “Coexisting gastric varices should not preclude prophylactic ligation of large esophageal varices in cirrhosis,” Digestion, vol. 80, no. 3, pp. 165–169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  193. E. J. Kang, S. W. Jeong, J. Y. Jang et al., “Long-term result of endoscopic Histoacryl (N-butyl-2- cyanoacrylate) injection for treatment of gastric varices,” World Journal of Gastroenterology, vol. 17, no. 11, pp. 1494–1500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  194. Y.-H. Huang, H.-Z. Yeh, G.-H. Chen et al., “Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety,” Gastrointestinal Endoscopy, vol. 52, no. 2, pp. 160–167, 2000. View at Scopus
  195. Y. T. Lee, F. K. Chan, E. K. Ng et al., “EUS-guided injection of cyanoacrylate for bleeding gastric varices,” Gastrointestinal Endoscopy, vol. 52, pp. 168–174, 2000.
  196. S. K. Sarin, A. K. Jain, M. Jain, and R. Gupta, “A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices,” American Journal of Gastroenterology, vol. 97, no. 4, pp. 1010–1015, 2002. View at Publisher · View at Google Scholar · View at Scopus
  197. G.-H. Lo, K.-H. Lai, J.-S. Cheng, M.-H. Chen, and H.-T. Chiang, “A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices,” Hepatology, vol. 33, no. 5, pp. 1060–1064, 2001. View at Publisher · View at Google Scholar · View at Scopus
  198. P. C. Tan, M. C. Hou, H. C. Lin et al., “A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation,” Hepatology, vol. 43, pp. 690–697, 2006.
  199. K. Barange, J.-M. Péron, K. Imani et al., “Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices,” Hepatology, vol. 30, no. 5, pp. 1139–1143, 1999. View at Publisher · View at Google Scholar · View at Scopus
  200. T. N. Chau, D. Patch, Y. W. Chan, A. Nagral, R. Dick, and A. K. Burroughs, “'Salvage' transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding,” Gastroenterology, vol. 114, no. 5, pp. 981–987, 1998. View at Scopus
  201. C.-Y. Wu, H.-Z. Yeh, and G.-H. Chen, “Pharmacologic efficacy in gastric variceal rebleeding and survival: including multivariate analysis,” Journal of Clinical Gastroenterology, vol. 35, no. 2, pp. 127–132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  202. S. Evrard, J.-M. Dumonceau, M. Delhaye, P. Golstein, J. Devière, and O. Le Moine, “Endoscopic histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial,” Endoscopy, vol. 35, no. 9, pp. 729–735, 2003. View at Publisher · View at Google Scholar · View at Scopus
  203. G.-H. Lo, H.-L. Liang, W.-C. Chen et al., “A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding,” Endoscopy, vol. 39, no. 8, pp. 679–685, 2007. View at Publisher · View at Google Scholar · View at Scopus
  204. N. J. Procaccini, A. M. S. Al-Osaimi, P. Northup, C. Argo, and S. H. Caldwell, “Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis,” Gastrointestinal Endoscopy, vol. 70, no. 5, pp. 881–887, 2009. View at Publisher · View at Google Scholar · View at Scopus
  205. P. Cales, B. Zabotto, C. Meskens et al., “Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction,” Gastroenterology, vol. 98, no. 1, pp. 156–162, 1990. View at Scopus
  206. S. Vigneri, R. Termini, A. Piraino, A. Scialabba, G. Pisciotta, and N. Fontana, “The stomach in liver cirrhosis: endoscopic, morphological, and clinical correlations,” Gastroenterology, vol. 101, no. 2, pp. 472–478, 1991. View at Scopus
  207. R. Cubillas and D. C. Rockey, “Portal hypertensive gastropathy: a review,” Liver International, vol. 30, no. 8, pp. 1094–1102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  208. T. T. McCormack, J. Sims, and I. Eyre-Brook, “Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy?” Gut, vol. 26, no. 11, pp. 1226–1232, 1985. View at Scopus
  209. K. Tanoue, M. Hashizume, H. Wada, M. Ohta, S. Kitano, and K. Sugimachi, “Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study,” Gastrointestinal Endoscopy, vol. 38, no. 5, pp. 582–585, 1992. View at Scopus
  210. G. P. Spina, R. Arcidiacono, J. Bosch et al., “Gastric endoscopic features in portal hypertension: final Report of a Consensus Conference, Milan, Italy, September 19, 1992,” Journal of Hepatology, vol. 21, no. 3, pp. 461–467, 1994. View at Publisher · View at Google Scholar · View at Scopus
  211. S. K. Sarin, D. V. Sreenivas, D. Lahoti, and A. Saraya, “Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension,” Gastroenterology, vol. 102, no. 3, pp. 994–999, 1992. View at Scopus
  212. S. K. Sarin, H. M. Shahi, M. Jain, A. K. Jain, S. K. Issar, and N. S. Murthy, “The natural history of portal hypertensive gastropathy: influence of variceal eradication,” American Journal of Gastroenterology, vol. 95, no. 10, pp. 2888–2893, 2000. View at Publisher · View at Google Scholar · View at Scopus
  213. M. Primignani, L. Carpinelli, P. Preatoni et al., “Natural history of portal hypertensive gastropathy in patients with liver cirrhosis,” Gastroenterology, vol. 119, no. 1, pp. 181–187, 2000. View at Scopus
  214. C. J. Gostout, T. R. Viggiano, and R. K. Balm, “Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features,” American Journal of Gastroenterology, vol. 88, no. 12, pp. 2030–2033, 1993. View at Scopus
  215. S. W. Hosking, H. J. Kennedy, I. Seddon, and D. R. Triger, “The role of propranolol in congestive gastropathy of portal hypertension,” Hepatology, vol. 7, no. 3, pp. 437–441, 1987. View at Scopus
  216. Y. Zhou, L. Qiao, J. Wu, H. Hu, and C. Xu, “Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: a controlled study,” Journal of Gastroenterology and Hepatology, vol. 17, no. 9, pp. 973–979, 2002. View at Publisher · View at Google Scholar · View at Scopus
  217. R. Bruha, Z. Marecek, J. Spicak et al., “Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding,” Hepato-Gastroenterology, vol. 49, no. 46, pp. 1161–1166, 2002. View at Scopus
  218. M. J. Orloff, M. S. Orloff, S. L. Orloff, and K. S. Haynes, “Treatment of bleeding from portal hypertensive gastropathy by portacaval shunt,” Hepatology, vol. 21, no. 4, pp. 1011–1017, 1995. View at Scopus
  219. J. Urata, Y. Yamashita, T. Tsuchigame et al., “The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy,” Journal of Gastroenterology and Hepatology, vol. 13, no. 10, pp. 1061–1067, 1998. View at Scopus
  220. R. M. Perez-Ayuso, J. M. Pique, J. Bosch et al., “Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis,” Lancet, vol. 337, no. 8755, pp. 1431–1434, 1991. View at Publisher · View at Google Scholar · View at Scopus
  221. T. Sato, J. Akaike, J. Toyota, Y. Karino, and T. Ohmura, “Clinicopathological features and treatment of ectopic varices with portal hypertension,” International Journal of Hepatology, vol. 2011, Article ID 960720, 9 pages, 2011. View at Publisher · View at Google Scholar
  222. D. Lebrec and J.-P. Benhamou, “Ectopic varices in portal hypertension,” Clinics in Gastroenterology, vol. 14, no. 1, pp. 105–121, 1985. View at Scopus
  223. M. A. Almadi, A. Almessabi, P. Wong, P. M. Ghali, and A. Barkun, “Ectopic varices,” Gastrointestinal Endoscopy, vol. 74, no. 2, pp. 380–388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  224. S. Kitano, J. Terblanche, D. Kahn, and P. C. Bornman, “Venous anatomy of the lower oesophagus in portal hypertension: practical implications,” British Journal of Surgery, vol. 73, no. 7, pp. 525–531, 1986. View at Scopus
  225. R. A. J. Spence, “The venous anatomy of the lower oesophagus in normal subjects and in patients with varices: an image analysis study,” British Journal of Surgery, vol. 71, no. 10, pp. 739–744, 1984. View at Scopus
  226. M. Al-Mofarreh, M. Al-Moagel-Alfarag, T. Ashoor, and F. Shadoochy, “Duodenal varices. Report of 13 cases,” Zeitschrift für Gastroenterologie, vol. 24, no. 11, pp. 673–680, 1986. View at Scopus
  227. N. Watanabe, A. Toyonaga, S. Kojima et al., “Current status of ectopic varices in Japan: results of a survey by the Japan Society for Portal Hypertension,” Hepatology Research, vol. 40, no. 8, pp. 763–776, 2010. View at Publisher · View at Google Scholar · View at Scopus
  228. D. Arakawa, N. Ohmiya, M. Nakamura et al., “Outcome after enteroscopy for patients with obscure GI bleeding: diagnostic comparison between double-balloon endoscopy and videocapsule endoscopy,” Gastrointestinal Endoscopy, vol. 69, no. 4, pp. 866–874, 2009. View at Publisher · View at Google Scholar · View at Scopus
  229. S.-J. Tang, S. Zanati, E. Dubcenco et al., “Diagnosis of small-bowel varices by capsule endoscopy,” Gastrointestinal Endoscopy, vol. 60, no. 1, pp. 129–135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  230. P. Figueiredo, N. Almeida, C. Lérias et al., “Effect of portal hypertension in the small bowel: an endoscopic approach,” Digestive Diseases and Sciences, vol. 53, pp. 2144–2150, 2008.
  231. K. R. Canlas, B. M. Dobozi, S. Lin et al., “Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia,” Journal of Clinical Gastroenterology, vol. 42, no. 7, pp. 844–848, 2008. View at Publisher · View at Google Scholar · View at Scopus
  232. S. Goulas, K. Triantafyllidou, S. Karagiannis et al., “Capsule endoscopy in the investigation of patients with portal hypertension and anemia,” Canadian Journal of Gastroenterology, vol. 22, no. 5, pp. 469–474, 2008. View at Scopus
  233. S. P. Misra, M. Dwivedi, V. Misra, and M. Gupta, “Ileal varices and portal hypertensive ileopathy in patients with cirrhosis and portal hypertension,” Gastrointestinal Endoscopy, vol. 60, no. 5, pp. 778–783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  234. A. C. Bernard, P. F. Hagihara, V. J. Burke, and M. Kugelmas, “Endoscopic localization and management of colonic bleeding in patients with portal hypertension,” Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, vol. 11, no. 3, pp. 195–198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  235. R. K. Dhiman, V. A. Saraswat, G. Choudhuri, B. C. Sharma, R. Pandey, and S. R. Naik, “Endosonographic, endoscopic, and histologic evaluation of alterations in the rectal venous system in patients with portal hypertension,” Gastrointestinal Endoscopy, vol. 49, no. 2, pp. 218–227, 1999. View at Publisher · View at Google Scholar · View at Scopus
  236. U. C. Ghoshal, P. K. Biswas, G. Roy, B. B. Pal, K. Dhar, and P. K. Banerjee, “Colonic mucosal changes in portal hypertension,” Tropical Gastroenterology, vol. 22, no. 1, pp. 25–27, 2001. View at Scopus
  237. S. W. Hosking, A. G. Johnson, H. L. Smart, and D. R. Triger, “Anorectal varices, haemorrhoids, and portal hypertension,” Lancet, vol. 1, no. 8634, pp. 349–352, 1989. View at Scopus
  238. Y. Chawla and J. B. Dilawari, “Anorectal varices—their frequency in cirrhotic and non-cirrhotic portal hypertension,” Gut, vol. 32, no. 3, pp. 309–311, 1991. View at Scopus
  239. R. H. Wiesner, N. F. LaRusso, R. R. Dozois, and S. J. Beaver, “Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis,” Gastroenterology, vol. 90, no. 2, pp. 316–322, 1986. View at Scopus
  240. C. Fucini, B. G. Wolff, and R. R. Dozois, “Bleeding from peristomal varices: perspectives on prevention and treatment,” Diseases of the Colon and Rectum, vol. 34, no. 12, pp. 1073–1078, 1991. View at Scopus
  241. M. Kinkhabwala, A. Mousavi, S. Iyer, and R. Adamsons, “Bleeding ileal varicosity demonstrated by transhepatic portography,” American Journal of Roentgenology, vol. 129, no. 3, pp. 514–516, 1977. View at Scopus
  242. D. K. Bhasin, B. C. Sharma, P. V. J. Sriram, G. Makharia, K. Singh, and B. W. Jeppsson, “Endoscopic management of bleeding ectopic varices with histoacryl,” HPB Surgery, vol. 11, no. 3, pp. 171–173, 1999. View at Scopus
  243. W.-C. Chen, M.-C. Hou, H.-C. Lin, F.-Y. Chang, and S.-D. Lee, “An endoscopic injection with N-butyl-2-cyanoacrylate used for colonic variceal bleeding: a case report and review of the literature,” American Journal of Gastroenterology, vol. 95, no. 2, pp. 540–542, 2000. View at Publisher · View at Google Scholar · View at Scopus
  244. G. P. Gertsch Ph. and L. H. Blumgart, “Cure of a bleeding duodenal varix by sclerotherapy,” British Journal of Surgery, vol. 75, no. 7, p. 717, 1988. View at Scopus
  245. J. R. Kirkpatrick, J. P. Shoenut, and A. B. Micflikier, “Successful injection sclerotherapy for bleeding duodenal varix in intrahepatic portal obstruction,” Gastrointestinal Endoscopy, vol. 31, no. 4, pp. 259–260, 1985. View at Scopus
  246. T. Sauerbruch, M. Weinzierl, and H. P. Dietrich, “Sclerotherapy of a bleeding duodenal varix,” Endoscopy, vol. 14, no. 5, pp. 187–189, 1982. View at Scopus
  247. H. Tsuji, H. Okano, H. Fujino et al., “A case of endoscopic injection sclerotherapy for a bleeding duodenal varix,” Gastroenterologia Japonica, vol. 24, no. 1, pp. 60–64, 1989. View at Scopus
  248. Y. Yoshida, Y. Imai, M. Nishikawa et al., “Successful endoscopic injection sclerotherapy with N-butyl-2- cyanoacrylate following the recurrence of bleeding soon after endoscopic ligation for ruptured duodenal varices,” American Journal of Gastroenterology, vol. 92, no. 7, pp. 1227–1229, 1997. View at Scopus
  249. O. Rahmani, L. M. Wolpert, and A. D. Drezner, “Distal inferior mesenteric veins to renal vein shunt for treatment of bleeding anorectal varices: case report and review of literature,” Journal of Vascular Surgery, vol. 36, no. 6, pp. 1264–1266, 2002. View at Publisher · View at Google Scholar · View at Scopus
  250. C.-S. Wang, L.-B. B. Jeng, and M.-F. Chen, “Duodenal variceal bleeding—successfully treated by mesocaval shunt after failure of sclerotherapy,” Hepato-Gastroenterology, vol. 42, no. 1, pp. 59–61, 1995. View at Scopus
  251. P. A. Johnson and J. Laurin, “Transjugular portosystemic shunt for treatment of bleeding stomal varices,” Digestive Diseases and Sciences, vol. 42, no. 2, pp. 440–442, 1997. View at Publisher · View at Google Scholar · View at Scopus
  252. L. McChesney, D. Jensen, T. Matalon et al., “Duodenal varices: a case report and review of the literature,” HPB Surgery, vol. 9, no. 1, pp. 31–35, 1995. View at Scopus
  253. R. C. K. Wong and C. L. Berg, “Portal hypertensive stomapathy: a newly described entity and its successful treatment by placement of a transjugular intrahepatic portosystemic shunt,” American Journal of Gastroenterology, vol. 92, no. 6, pp. 1056–1057, 1997. View at Scopus
  254. D. Shibata, D. P. Brophy, F. D. Gordon, H. T. Anastopoulos, S. M. Sentovich, and R. Bleday, “Transjugular intrahepatic portosystemic shunt for treatment of bleeding ectopic varices with portal hypertension,” Diseases of the Colon and Rectum, vol. 42, no. 12, pp. 1581–1585, 1999. View at Scopus
  255. M. Vangeli, D. Patch, N. Terreni et al., “Bleeding ectopic varices—treatment with transjugular intrahepatic porto-systemic shunt (TIPS) and embolisation,” Journal of Hepatology, vol. 41, no. 4, pp. 560–566, 2004. View at Publisher · View at Google Scholar · View at Scopus
  256. Y. Akazawa, I. Murata, T. Yamao et al., “Successful management of bleeding duodenal varices by endoscopic variceal ligation and balloon-occluded retrograde transvenous obliteration,” Gastrointestinal Endoscopy, vol. 58, no. 5, pp. 794–797, 2003. View at Publisher · View at Google Scholar · View at Scopus
  257. M. Ohta, K. Yasumori, M. Saku, H. Saitsu, T. Muranaka, and K. Yoshida, “Successful treatment of bleeding duodenal varices by balloon-occluded retrograde transvenous obliteration: a transjugular venous approach,” Surgery, vol. 126, no. 3, pp. 581–583, 1999. View at Publisher · View at Google Scholar · View at Scopus